SK bioscience Co.,Ltd. (KRX:302440)
41,450
-2,300 (-5.26%)
At close: Mar 9, 2026
SK bioscience Market Cap
SK bioscience has a market cap or net worth of 3.25 trillion as of March 9, 2026. Its market cap has decreased by -15.05% in one year.
Market Cap
3.25T
Enterprise Value
2.90T
Revenue
624.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
41,450.00
Market Cap Chart
Since March 18, 2021, SK bioscience's market cap has decreased from 12.93T to 3.25T, a decrease of -74.85%. That is a compound annual growth rate of -24.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 3,251.12B | -13.96% |
| Dec 30, 2025 | 3,778.45B | -4.31% |
| Dec 30, 2024 | 3,948.70B | -28.57% |
| Dec 28, 2023 | 5,528.45B | -2.04% |
| Dec 29, 2022 | 5,643.63B | -67.21% |
| Dec 30, 2021 | 17.21T | 33.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaResearch | 3,459.75B |
| D&D Pharmatech | 3,652.62B |
| Hugel | 2,824.54B |
| OliX Pharmaceuticals | 4,179.31B |
| Orum Therapeutics | 2,490.56B |
| Voronoi | 5,927.74B |
| Peptron | 6,132.46B |
| Chabiotech | 1,820.72B |